type here...
type here...
START FREE TRIAL

M&A

Technology & AIM&AHealthcareConsumer & RetailMiscellaneousEnergy

Merck’s $11 BillionBio-Techne Deal Looks Strategic, But The Debt Trade-Off Is REAL

M&A Ishan Majumdar -
Merck KGaA (ETR:MRK) has made a bold early move under new CEO Kai Beckmann. The German drug, chemicals, and life-sciences group agreed to buy...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

M&A Ishan Majumdar -
AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee Therapeutics for about $10.9 billion in cash. That is a huge number for a biotech...
spot_imgspot_img

Did Fox Pay $25 Billion For Roku’s Platform, Or Its Ad Data Edge?

M&A Ishan Majumdar -
Fox Corp (NASDAQ:FOXA) has made its biggest swing yet in streaming, agreeing to acquire Roku (NASDAQ:ROKU) in a cash-and-stock...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

M&A Ishan M. -
Incyte Corporation (NASDAQ:INCY) is back in the biotech deal spotlight. The company is reportedly nearing an agreement to acquire...

Sony Just Made Music IP Look Like A Bigger SHIFT Than Games

M&A Ishan M. -
Sony Group Corporation (NYSE:SONY) is leaning harder into the business of owning culture, not just distributing it. The latest...

Meta Doesn’t Want to Build the Metaverse. It Wants to Build Your Robot

M&A Ishan M. -
Meta Platforms (NASDAQ:META) just made the kind of acquisition that sounds small until you zoom out. The company acquired...

This Cybersecurity Stock Is DEFYING The Mythos Panic With Its Latest AI Acquisition!

M&A Ishan Majumdar -
Palo Alto Networks (NASDAQ:PANW) has found itself in a strange spot. The stock is still down more than 18%...

Everyone Thinks Eli Lilly Is A Weight-Loss Stock. That’s The Trap

M&A Ishan Majumdar -
Eli Lilly (NYSE:LLY) is having one of those rare market moments where everyone thinks they understand the story. Weight-loss...
Load more

Merck’s $11 BillionBio-Techne Deal Looks Strategic, But The Debt Trade-Off Is REAL

M&A Ishan Majumdar -
Merck KGaA (ETR:MRK) has made a bold early move under new CEO Kai Beckmann. The German drug, chemicals, and...

AbbVie’s $11 Billion Eczema Gamble Is Bigger Than Skin

M&A Ishan Majumdar -
AbbVie Inc. (NYSE:ABBV) may be close to buying Apogee Therapeutics for about $10.9 billion in cash. That is a...

Did Fox Pay $25 Billion For Roku’s Platform, Or Its Ad Data Edge?

M&A Ishan Majumdar -
Fox Corp (NASDAQ:FOXA) has made its biggest swing yet in streaming, agreeing to acquire Roku (NASDAQ:ROKU) in a cash-and-stock...

Incyte Acquisition Watch: The $2 Billion Star Therapeutics Deal That Could Change Its Story

M&A Ishan M. -
Incyte Corporation (NASDAQ:INCY) is back in the biotech deal spotlight. The company is reportedly nearing an agreement to acquire...

Sony Just Made Music IP Look Like A Bigger SHIFT Than Games

M&A Ishan M. -
Sony Group Corporation (NYSE:SONY) is leaning harder into the business of owning culture, not just distributing it. The latest...

Meta Doesn’t Want to Build the Metaverse. It Wants to Build Your Robot

M&A Ishan M. -
Meta Platforms (NASDAQ:META) just made the kind of acquisition that sounds small until you zoom out. The company acquired...

This Cybersecurity Stock Is DEFYING The Mythos Panic With Its Latest AI Acquisition!

M&A Ishan Majumdar -
Palo Alto Networks (NASDAQ:PANW) has found itself in a strange spot. The stock is still down more than 18%...

Everyone Thinks Eli Lilly Is A Weight-Loss Stock. That’s The Trap

M&A Ishan Majumdar -
Eli Lilly (NYSE:LLY) is having one of those rare market moments where everyone thinks they understand the story. Weight-loss...

Amazon vs Starlink Is The Story; But The REAL SHIFT Is Elsewhere!

M&A Ishan Majumdar -
Amazon (NASDAQ:AMZN) has never been shy about spending big when it sees a control point forming.The $10.8 billion Globalstar...

The “Boring” Healthcare Stock Making A $5 Billion POWER MOVE!

M&A Ishan M. -
The market loves excitement. But money is often made in boredom. That is what makes Gilead Sciences (NASDAQ:GILD) such...

This “Broken” Biotech Just Forced Wall Street To Blink

M&A Ishan Majumdar -
Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle on Tuesday. What changed was the price investors were willing...

This Widely Held “Defensive” Stock Is Now Tied To A Large Scale Merger

M&A Ishan Majumdar -
For years, McCormick (NYSE:MKC) has been framed as one of those dependable staples names investors can tuck away and...
Load more

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

Is WildFire The Acquisition That Expands Magnolia, Or Stretches Its Model?

0
Magnolia Oil & Gas Corporation (NYSE:MGY) has moved into...

Is Ross The Anti-Amazon Retail Story With A REAL Valuation Catch Now?

0
Ross Stores (NASDAQ:ROST) is doing something that sounds almost...

Merck’s $11 BillionBio-Techne Deal Looks Strategic, But The Debt Trade-Off Is REAL

0
Merck KGaA (ETR:MRK) has made a bold early move...

AI’s $3 Trillion Bill Just Arrived at the Apple Store. Here’s What Comes Next.

0
Your next MacBook is $200 more expensive. Your next...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 Baptista Research. All rights reserved.